Decibel Therapeutics Appoints Cynthia Hu as Chief Legal Officer and Corporate Secretary
18 août 2021 07h30 HE
|
Decibel Therapeutics, Inc.
BOSTON, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and...
Blameless Secures $30M Series B Funding to Fuel Growth for Site Reliability Engineering Solutions
27 juil. 2021 09h00 HE
|
Blameless
SAN MATEO, Calif., July 27, 2021 (GLOBE NEWSWIRE) -- Blameless, the industry's leading end-to-end Site Reliability Engineering (SRE) platform, today announced a $30 million Series B funding round...
Decibel Therapeutics Appoints Dr. William H. Carson as Chairman of the Board of Directors
02 juin 2021 08h30 HE
|
Decibel Therapeutics, Inc.
BOSTON, June 02, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and...
Decibel Therapeutics Expands World-Class Scientific Advisory Board
24 mai 2021 16h15 HE
|
Decibel Therapeutics, Inc.
BOSTON, May 24, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and...
Decibel Therapeutics to Present at the UBS Global Healthcare Virtual Conference
19 mai 2021 08h00 HE
|
Decibel Therapeutics, Inc.
BOSTON, May 19, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and...
Decibel Therapeutics Reports First Quarter 2021 Financial Results and Corporate Update
13 mai 2021 17h05 HE
|
Decibel Therapeutics, Inc.
– Established cGMP manufacturing and development agreement with Catalent for otoferlin dual-vector gene therapy, DB-OTO – – Successfully completed the second tranche of an oversubscribed Series D...
Decibel Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference
08 avr. 2021 08h00 HE
|
Decibel Therapeutics, Inc.
BOSTON, April 08, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore...
Decibel Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Update
29 mars 2021 16h05 HE
|
Decibel Therapeutics, Inc.
-Successfully completed an oversubscribed Series D financing and upsized Initial Public Offering raising approximately $220.1M in gross proceeds- -Established development and manufacturing agreement...
Decibel Therapeutics Added to Russell 2000 Index
22 mars 2021 08h00 HE
|
Decibel Therapeutics, Inc.
BOSTON, March 22, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX) (“Decibel”), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments...